Tuftsin: A Natural Molecule Against SARS-CoV-2 Infection

Tuftsin: A Natural Molecule Against SARS-CoV-2 Infection

Coronavirus disease 2019 (COVID-19) continuously progresses despite the application of a variety of vaccines. Therefore, it is still imperative to find effective ways for treating COVID-19. Recent studies indicate that NRP1, an important receptor of the natural peptide tuftsin (released from IgG), f...

Full description

Bibliographic Details
Main Authors:	Jiahao Huang, Jing Wang, Yan Li, Ziyuan Wang, Ming Chu, Yuedan Wang
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2022-03-01
Series:	Frontiers in Molecular Biosciences
Subjects:	tuftsin SARS-CoV-2 ACE2 NRP1 natural peptide
Online Access:	https://www.frontiersin.org/articles/10.3389/fmolb.2022.859162/full

Similar Items

Receptors and Cofactors That Contribute to SARS-CoV-2 Entry: Can Skin Be an Alternative Route of Entry?
by: Manon Barthe, et al.
Published: (2023-03-01)

Tuftsin-Bearing Liposomes Co-Encapsulated with Doxorubicin and Curcumin Efficiently Inhibit EAC Tumor Growth in Mice
by: Murugesan K, et al.
Published: (2020-12-01)

Inhibition of HeLa cell growth by doxorubicin-loaded and tuftsin-conjugated arginate-PEG microparticles
by: Tianmu Hu, et al.
Published: (2018-03-01)

Genetic Variants within SARS-CoV-2 Human Receptor Genes May Contribute to Variable Disease Outcomes in Different Ethnicities
by: Theolan Adimulam, et al.
Published: (2023-05-01)

Spread of Mink SARS-CoV-2 Variants in Humans: A Model of Sarbecovirus Interspecies Evolution
by: Christian A. Devaux, et al.
Published: (2021-09-01)

Emerging SARS-CoV-2 variants of concern potentially expand host range to chickens: insights from AXL, NRP1 and ACE2 receptors
by: Mengyue Lei, et al.
Published: (2023-08-01)

Susceptibility of bovine to SARS-CoV-2 variants of concern: insights from ACE2, AXL, and NRP1 receptors
by: Ying Ma, et al.
Published: (2023-11-01)

Polymorphisms within the SARS-CoV-2 Human Receptor Genes Associate with Variable Disease Outcomes across Ethnicities
by: Theolan Adimulam, et al.
Published: (2023-09-01)

Tuftsin-Phosphorylcholine Maintains Normal Gut Microbiota in Collagen Induced Arthritic Mice
by: Hila Ben-Amram, et al.
Published: (2017-07-01)

New Insights into the Link between SARS-CoV-2 Infection and Renal Cancer
by: Vittoria Rago, et al.
Published: (2023-12-01)

Role of tannic acid against SARS-cov-2 cell entry by targeting the interface region between S-protein-RBD and human ACE2
by: Xi Chen, et al.
Published: (2022-08-01)

Characterization of the SARS-CoV-2 co-receptor NRP1 expression profiles in healthy people and cancer patients: Implication for susceptibility to COVID-19 disease and potential therapeutic strategy
by: Yongbiao Huang, et al.
Published: (2022-10-01)

Tuftsin-tailored fusion protein inhibits the growth of circulating gastric tumor cells associated with macrophage phagocytosis
by: Dandan Yuan, et al.
Published: (2023-07-01)

The Role of Neuropilin-1 (NRP-1) in SARS-CoV-2 Infection: Review
by: Monika Gudowska-Sawczuk, et al.
Published: (2021-06-01)

Bioengineered probiotics to control SARS-CoV-2 infection
by: Shantibhusan Senapati, et al.
Published: (2020-05-01)

SARS-CoV-2 Cellular Entry Is Independent of the ACE2 Cytoplasmic Domain Signaling
by: Thankamani Karthika, et al.
Published: (2021-07-01)

Human ACE2 Genetic Polymorphism Affecting SARS-CoV and SARS-CoV-2 Entry into Cells
by: Takanari Hattori, et al.
Published: (2022-08-01)

Lack of antibody-mediated cross-protection between SARS-CoV-2 and SARS-CoV infections
by: Ren Yang, et al.
Published: (2020-08-01)

Importance of ACE2 for SARS-CoV-2 Infection of Kidney Cells
by: Marie-Kristin Kroll, et al.
Published: (2023-03-01)

Interaction of Human ACE2 to Membrane-Bound SARS-CoV-1 and SARS-CoV-2 S Glycoproteins
by: Sai Priya Anand, et al.
Published: (2020-09-01)

Characterization of MW06, a human monoclonal antibody with cross-neutralization activity against both SARS-CoV-2 and SARS-CoV
by: Wen Jiang, et al.
Published: (2021-01-01)

Stability of ACE2 Peptide Mimetics and Their Implications on the Application for SARS-CoV2 Detection
by: Paula A. Santana, et al.
Published: (2023-04-01)

Structurally Modified Bioactive Peptide Inhibits SARS-CoV-2 Lentiviral Particles Expression
by: Khushwant S. Bhullar, et al.
Published: (2022-09-01)

Comparison of Selected Characteristics of SARS-CoV-2, SARS-CoV, and HCoV-NL63
by: Darina Bačenková, et al.
Published: (2021-02-01)

Transcriptional regulation of SARS-CoV-2 receptor ACE2 by SP1
by: Hui Han, et al.
Published: (2024-02-01)

SARS-CoV-2 pan-variant inhibitory peptides deter S1-ACE2 interaction and neutralize delta and omicron pseudoviruses
by: Masaud Shah, et al.
Published: (2022-01-01)

An update on the interaction between COVID-19, vaccines, and diabetic kidney disease
by: Yang Yang, et al.
Published: (2022-10-01)

The impact of ACE2 and co‐factors on SARS‐CoV‐2 infection in colorectal cancer
by: Shuwei Li, et al.
Published: (2022-07-01)

Glycyrrhizin Inhibits SARS-CoV-2 Entry into Cells by Targeting ACE2
by: Ming-Feng He, et al.
Published: (2022-10-01)

Assessing the therapeutic potential of agomelatine, ramelteon, and melatonin against SARS-CoV-2
by: Pradeep Kumar Yadalam, et al.
Published: (2022-05-01)

Drug Weaponry to Fight Against SARS-CoV-2
by: Elena Cabezón, et al.
Published: (2020-08-01)

A Collection of Designed Peptides to Target SARS-CoV-2 Spike RBD—ACE2 Interaction
by: Narcis Fernandez-Fuentes, et al.
Published: (2021-10-01)

“Molecular Masks” for ACE2 to Effectively and Safely Block SARS-CoV-2 Virus Entry
by: Satya Prakash Shukla, et al.
Published: (2021-08-01)

Variation in the ACE2 receptor has limited utility for SARS-CoV-2 host prediction
by: Nardus Mollentze, et al.
Published: (2022-11-01)

Mini-Review: SARS-CoV-2 and COVID-19
by: Dhurgham A .H. Alhasan, et al.
Published: (2021-04-01)

ACE2: the molecular doorway to SARS-CoV-2
by: Miriam Marlene Medina-Enríquez, et al.
Published: (2020-12-01)

Body Localization of ACE-2: On the Trail of the Keyhole of SARS-CoV-2
by: Francesca Salamanna, et al.
Published: (2020-12-01)

Metalloprotease-Dependent S2′-Activation Promotes Cell–Cell Fusion and Syncytiation of SARS-CoV-2
by: James V. Harte, et al.
Published: (2022-09-01)

How the Competition for Cysteine May Promote Infection of SARS-CoV-2 by Triggering Oxidative Stress
by: Annamaria Vernone, et al.
Published: (2023-02-01)

Structural Bases of Zoonotic and Zooanthroponotic Transmission of SARS-CoV-2
by: Emily Clayton, et al.
Published: (2022-02-01)